Gabelli Funds LLC Bausch Health Companies Inc. Transaction History

Gabelli Funds LLC

$12.8 Billion
Q3 2024

A detailed history of Gabelli Funds LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Gabelli Funds LLC holds 57,800 shares of BHC stock, worth $490,144. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,800

Previous 60,800 4.93%

Holding current value

$490,144

Previous $423,000 11.35%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$5.22 - $8.26 $15,660 - $24,780	-3,000 Reduced 4.93%	57,800 $471,000
Q2 2024 Aug 13, 2024	SELL	$6.1 - $10.41 $37,820 - $64,542	-6,200 Reduced 9.25%	60,800 $423,000
Q4 2023 Feb 13, 2024	SELL	$6.53 - $8.23 $156,720 - $197,520	-24,000 Reduced 26.37%	67,000 $537,000
Q3 2023 Nov 08, 2023	SELL	$7.69 - $9.71 $15,380 - $19,420	-2,000 Reduced 2.15%	91,000 $748,000
Q1 2023 May 12, 2023	BUY	$6.28 - $9.85 $12,560 - $19,700	2,000 Added 2.2%	93,000 $753,000
Q4 2022 Feb 13, 2023	SELL	$6.09 - $7.93 $895,230 - $1.17 Million	-147,000 Reduced 61.76%	91,000 $571,000
Q3 2022 Nov 10, 2022	SELL	$4.58 - $9.21 $1.41 Million - $2.84 Million	-308,500 Reduced 56.45%	238,000 $1.64 Million
Q2 2022 Aug 12, 2022	BUY	$7.06 - $23.63 $134,846 - $451,333	19,100 Added 3.62%	546,500 $4.57 Million
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $150,012 - $193,001	6,945 Added 1.33%	527,400 $12.1 Million
Q4 2021 Feb 11, 2022	BUY	$23.0 - $29.01 $2.25 Million - $2.84 Million	97,900 Added 23.17%	520,455 $14.4 Million
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $1.15 Million - $1.38 Million	-46,000 Reduced 9.82%	422,555 $11.8 Million
Q2 2021 Aug 13, 2021	SELL	$27.43 - $32.7 $192,010 - $228,900	-7,000 Reduced 1.47%	468,555 $13.7 Million
Q1 2021 May 14, 2021	BUY	$21.37 - $34.38 $652,960 - $1.05 Million	30,555 Added 6.87%	475,555 $15.1 Million
Q4 2020 Feb 05, 2021	SELL	$15.31 - $21.12 $956,875 - $1.32 Million	-62,500 Reduced 12.32%	445,000 $9.26 Million
Q3 2020 Nov 06, 2020	BUY	$14.88 - $20.13 $334,800 - $452,925	22,500 Added 4.64%	507,500 $7.89 Million
Q2 2020 Aug 13, 2020	BUY	$13.31 - $20.51 $79,860 - $123,060	6,000 Added 1.25%	485,000 $8.87 Million
Q1 2020 May 14, 2020	BUY	$12.98 - $30.25 $1.31 Million - $3.06 Million	101,000 Added 26.72%	479,000 $7.43 Million
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $358,910 - $605,910	-19,000 Reduced 4.79%	378,000 $11.3 Million
Q3 2019 Nov 01, 2019	BUY	$20.88 - $25.66 $2.56 Million - $3.14 Million	122,500 Added 44.63%	397,000 $8.67 Million
Q2 2019 Aug 02, 2019	BUY	$20.52 - $26.45 $923,400 - $1.19 Million	45,000 Added 19.61%	274,500 $6.92 Million
Q1 2019 May 02, 2019	BUY	$20.23 - $26.29 $2.3 Million - $2.98 Million	113,500 Added 97.84%	229,500 $5.67 Million
Q3 2018 Nov 02, 2018	BUY	$20.64 - $25.67 $2.39 Million - $2.98 Million	116,000 New	116,000 $2.98 Million

Others Institutions Holding BHC

# of Institutions

255

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Bausch Health Companies Inc. Transaction History